Deal Activity Growthink Capital Research tracked 880 closed Merger & Acquisition transactions with U.S. targets in June 2024, consistent with the 885 tracked in May 2024. This total includes 379 Private Equity or Private Equity-backed acquisitions and 501 corporate acquisitions. The distribution of
Growthink Capital Research tracked $2.79 billion in new venture funding in July 2023, compared to the $4.36 billion tracked in June 2023. The month’s biggest funding event belonged to Smile
Growthink Capital Research tracked $4.36 billion in new venture funding in June 2023, a little increase compared to the $4.3 billion tracked in May 2023.
Growthink Capital Research tracked $4.3 billion in new venture funding in May 2023, up compared to $3.94 billion tracked in April 2023. The month’s biggest funding event belonged to ElevateBio ($410 million) a
Growthink Capital Research tracked $3.94 billion in new venture funding in April 2023 compared to $4.59 billion in March 2023. The month’s biggest funding event belonged
Growthink Capital Research tracked $4.59 billion in new venture funding in March 2023, increased from the $3.59 billion tracked in February 2023. The month’s biggest
Growthink Capital Research tracked $3.59 billion in new venture funding in February 2023, down from the $4.2 billion tracked in January 2023. The month’s biggest
Growthink Capital Research tracked $4.2 billion in new venture funding in January 2023, up 10.5% from the $3.8 billion tracked in December 2022. The month’s
The Portugal-based dental surgery group gains a foothold in the UK by acquiring two dental clinics in London Growthink Capital is pleased to announce it
In 2022, Growthink Capital Research tracked 1,574 venture financings, representing $91.3 billion in funding. The most active 2022 funding sectors were: Artificial Intelligence/Machine Learning –
5 Merchant Square, London W2 1AY, UK